Skip to main content
. Author manuscript; available in PMC: 2009 Dec 31.
Published in final edited form as: Drug News Perspect. 2008 Jul–Aug;21(6):331–335. doi: 10.1358/dnp.2008.21.6.1246832

Table 1.

Results of RRD-251 treatment in vivo

Experiment Dosage/Route Results p value
in vivo Matrigel plug
angiogenesis
50 MPK i.p. 50MPK: 6-fold reduction in
relative angiogenesis
0.0004
A549 Xenograft 50 MPK i.p
150 MPK-Oral
Vehicle:1040±128mm3
50 MPK: 145±20 mm3
150 MPK: 148±38 mm3
50 MPK:0.0008
150 MPK:0.0004
H1650 Xenograft 50 MPK i.p. Vehicle:2185±326mm3
50 MPK:557±76 mm3
0.003
SK-MEL-28/Matrigel
Xenograft
50 MPK i.p. Vehicle:861±106mm3
50 MPK:341±42 mm3
0.0003